30
Participants
Start Date
June 30, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
FST-100 Ophthalmic Suspension
FST-100 (PVP-I 0.4% and dexamethasone 0.1%). A regimen of 2 drops 4 times a day while awake for 5 days.
Placebo
A regimen of 2 drops 4 times a day while awake for 5 days.
Ophthalmic Consultants PC The New York Eye and Ear Infirmary, New York
Wantagh
Charlotte
The Center for Excellence in Eye, Miami
Ocean Ophthalmology, North Miami Beach
Columbus Ophthalmology Associates, Columbus
The Midwest Center for Sight, Des Plaines
Hoffman Estates
Silverstein Eye Centers, Kansas City
St. Johns Clinic, Springfield
Colorado Eye Associates, Colorado Springs
Wolstan and Goldberg Eye Associates, Torrance
Eye Center, Hamden
Lead Sponsor
Shire
INDUSTRY